Skip to content

The use of sit-stand desks by GPs during consultations with adult patients

The feasibility and acceptability of using height-adjustable workstations to facilitate standing during GP consultations with adult patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN76982860
Enrollment
340
Registered
2021-03-17
Start date
2021-04-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedentary general practitioners (GPs) Not Applicable Sedentary lifestyle

Interventions

GPs will be identified through the West Midlands Clinical Research Network. Practices will be contacted and interested GPs within each practice will be able to contact the research team if they are in
sex
work address
year qualified as a GP
location of current working practice (City, Town, Rural)
current job role
number of clinical sessions worked per week
number of patients registered at their practice
and whether their practice is accredited by the RCGP active practice charter, the workplace wellbeing charter, or are a registered parkrun practice. GPs will then be asked to complete a short question

Sponsors

Loughborough University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: GPs: 1. Currently working as a GP in the UK 2. Working at least five clinical sessions a week Patients: 1. Aged =18 years 2. Attended a consultation with a GP who was standing as part of their participation in the study

Exclusion criteria

Exclusion criteria: GPs: 1. Medical student who is not yet qualified as a GP 2. Any other health care professional 3. Pre-existing condition that inhibits the ability to stand or to be physically active Patients: 1. Unable to communicate in English 2. Unable to provide written informed consent

Design outcomes

Primary

MeasureTime frame
1. Feasibility and acceptability of using height-adjustable workstations measured using GP questionnaires at baseline and between 4 weeks, and a patient questionnaire immediately after the consultation

Secondary

MeasureTime frame
1. GP view of the doctor-patient relationship measured using questionnaires at baseline and 4 weeks 2. Patient view of the doctor-patient relationship measured using a patient questionnaire immediately after the consultation 3. Patient views of standing during their GP consultation measured using a patient questionnaire immediately after the consultation 4. Patient views of standing during their GP consultation measured during an optional patient follow-up telephone interview 5. Desk use measured using a GP questionnaire atv4 weeks and via a limpet device between baseline and 4 weeks 6. Sitting time and physical activity measured using the activPAL for an 8 day period at baseline and for the last 8 days of the 4-week intervention 7. Establish and refine a study recruitment strategy for GPs and patients measured using trial records collected during the recruitment period 8. Attrition in the trial GPs measured using trial records collected throughout the study 9. GP views of the feasibility and acceptability of using sit-stand desks within General Practice measured using a GP interview between 4 and 8 weeks 10. Trial recruitment, retention, and acceptability between ethnic groups, gender, and practice location for GPs measured using demographic data collected at baseline and trial records collected throughout the study 11. Acceptability of measurement instruments to GPs and patients, including the activPAL inclinometer as the tool for the measurement of sitting time and physical activity in GPs measured using an optional patient follow-up telephone interview and GP interview between 4 and 8 weeks 12. Intervention fidelity measured using trial records collected throughout the study 13. Standard deviation of sitting time to inform a sample size calculation for a potential phase III RCT calculated from activPAL data collected for an 8 day period at baseline and for the last 8 days of the 4-week intervention

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026